LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 204 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,293,014 | -16.9% | 21,579 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,555,846 | -11.5% | 21,579 | -9.7% | 0.00% | 0.0% |
| Q1 2023 | $1,757,348 | +3.9% | 23,890 | -5.7% | 0.00% | 0.0% |
| Q4 2022 | $1,691,643 | -22.4% | 25,324 | +0.1% | 0.00% | 0.0% |
| Q3 2022 | $2,179,000 | -3.9% | 25,308 | -0.4% | 0.00% | 0.0% |
| Q2 2022 | $2,267,000 | -20.5% | 25,407 | +0.2% | 0.00% | 0.0% |
| Q1 2022 | $2,853,000 | -26.8% | 25,363 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $3,898,000 | +1.6% | 25,239 | -8.3% | 0.00% | -50.0% |
| Q3 2021 | $3,836,000 | -30.2% | 27,534 | -34.3% | 0.00% | 0.0% |
| Q2 2021 | $5,497,000 | -19.6% | 41,902 | -6.6% | 0.00% | -33.3% |
| Q1 2021 | $6,839,000 | +56.1% | 44,862 | +1.9% | 0.00% | +50.0% |
| Q4 2020 | $4,380,000 | -24.2% | 44,045 | -27.3% | 0.00% | -33.3% |
| Q3 2020 | $5,777,000 | -23.2% | 60,608 | -9.9% | 0.00% | -25.0% |
| Q2 2020 | $7,520,000 | +51.8% | 67,231 | -1.3% | 0.00% | 0.0% |
| Q1 2020 | $4,955,000 | -30.0% | 68,141 | +0.4% | 0.00% | 0.0% |
| Q4 2019 | $7,077,000 | +2.2% | 67,861 | -2.5% | 0.00% | 0.0% |
| Q3 2019 | $6,927,000 | -14.3% | 69,591 | -1.7% | 0.00% | -20.0% |
| Q2 2019 | $8,081,000 | -12.9% | 70,791 | -4.1% | 0.01% | -16.7% |
| Q1 2019 | $9,283,000 | -3.7% | 73,841 | +4.0% | 0.01% | -14.3% |
| Q4 2018 | $9,636,000 | -24.4% | 71,011 | +53.0% | 0.01% | -12.5% |
| Q3 2018 | $12,739,000 | +31.6% | 46,409 | -0.6% | 0.01% | +14.3% |
| Q2 2018 | $9,677,000 | +28.1% | 46,709 | +2.1% | 0.01% | +40.0% |
| Q1 2018 | $7,554,000 | +19.8% | 45,739 | -0.7% | 0.01% | 0.0% |
| Q4 2017 | $6,307,000 | +0.6% | 46,059 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $6,271,000 | +12.1% | 46,059 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $5,592,000 | +37.6% | 46,059 | +19.9% | 0.00% | +33.3% |
| Q1 2017 | $4,064,000 | +23.4% | 38,399 | +18.5% | 0.00% | 0.0% |
| Q4 2016 | $3,293,000 | -0.5% | 32,409 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $3,308,000 | -14.4% | 32,409 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,865,000 | +29.8% | 32,409 | +16.5% | 0.00% | 0.0% |
| Q1 2016 | $2,978,000 | -11.4% | 27,809 | -10.3% | 0.00% | 0.0% |
| Q4 2015 | $3,362,000 | +12.9% | 31,009 | -10.8% | 0.00% | 0.0% |
| Q3 2015 | $2,977,000 | -23.9% | 34,759 | -10.4% | 0.00% | 0.0% |
| Q2 2015 | $3,914,000 | +27.6% | 38,789 | -2.5% | 0.00% | +50.0% |
| Q1 2015 | $3,068,000 | +44.9% | 39,789 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,117,000 | +13.2% | 39,789 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,870,000 | -24.5% | 39,789 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $2,478,000 | -7.6% | 39,789 | -0.3% | 0.00% | 0.0% |
| Q1 2014 | $2,683,000 | +50.5% | 39,894 | +17.7% | 0.00% | 0.0% |
| Q4 2013 | $1,783,000 | +15.1% | 33,901 | -5.3% | 0.00% | 0.0% |
| Q3 2013 | $1,549,000 | +8.6% | 35,795 | -6.1% | 0.00% | 0.0% |
| Q2 2013 | $1,426,000 | – | 38,115 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |